Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 25.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 81,908 shares of the pharmacy operator's stock after selling 28,290 shares during the period. State of Alaska Department of Revenue's holdings in Walgreens Boots Alliance were worth $764,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Centennial Wealth Advisory LLC boosted its stake in shares of Walgreens Boots Alliance by 44.6% during the fourth quarter. Centennial Wealth Advisory LLC now owns 24,750 shares of the pharmacy operator's stock valued at $231,000 after acquiring an additional 7,637 shares during the last quarter. Robertson Stephens Wealth Management LLC boosted its stake in shares of Walgreens Boots Alliance by 11.8% during the fourth quarter. Robertson Stephens Wealth Management LLC now owns 12,220 shares of the pharmacy operator's stock valued at $114,000 after acquiring an additional 1,289 shares during the last quarter. Choreo LLC lifted its position in Walgreens Boots Alliance by 17.0% during the fourth quarter. Choreo LLC now owns 110,932 shares of the pharmacy operator's stock worth $1,032,000 after buying an additional 16,103 shares during the period. Money Concepts Capital Corp lifted its position in Walgreens Boots Alliance by 10.0% during the fourth quarter. Money Concepts Capital Corp now owns 64,396 shares of the pharmacy operator's stock worth $601,000 after buying an additional 5,849 shares during the period. Finally, Lion Street Advisors LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter worth about $261,000. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Up 12.7 %

Shares of NASDAQ:WBA traded up $1.24 during mid-day trading on Tuesday, hitting $10.94. 26,964,305 shares of the company traded hands, compared to its average volume of 26,831,969. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.47. The firm's 50 day simple moving average is $10.33 and its 200 day simple moving average is $9.71. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a market cap of $9.45 billion, a P/E ratio of -1.07, a PEG ratio of 1.26 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the firm earned $0.66 EPS. Walgreens Boots Alliance's quarterly revenue was up 7.6% on a year-over-year basis. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analysts Forecast Growth

WBA has been the topic of several recent analyst reports. Evercore ISI increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research report on Monday, January 13th. Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Jefferies Financial Group cut their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating on the stock in a report on Wednesday, October 23rd. Finally, TD Cowen cut their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating on the stock in a report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has an average rating of "Hold" and an average target price of $13.19.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.